TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop.

Transforming growth factor-beta (TGF-beta) acts as a growth inhibitor, yet it can stimulate proliferation; 1-2 fg/cell of TGF-beta 1 elicits maximal proliferation of dense and sparse cultured smooth muscle cells (SMCs), whereas higher amounts are less stimulatory. This bimodal response is not limited to SMCs, as TGF-beta induces a similar response in human fibroblasts and chondrocytes. The amount of TGF-beta 1 per cell that induces maximal proliferation is identical for dense and sparse SMCs. At low concentrations of TGF-beta, there is a 10-12 hr delay in DNA synthesis compared with that elicited by PDGF. PDGF-AA is detected in the culture medium at 24 hr, and anti-PDGF IgG blocks DNA synthesis. At higher concentrations, TGF-beta 1 decreases transcripts and expression of PDGF receptor alpha subunits. Hence, TGF-beta induces proliferation of connective tissue cells at low concentrations by stimulating autocrine PDGF-AA secretion, which at higher concentrations of TGF-beta, is decreased by down-regulation of PDGF receptor alpha subunits and perhaps by direct growth inhibition.

[1]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[2]  M. Majesky,et al.  Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta , 1990, The Journal of cell biology.

[3]  F. Welt,et al.  Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2- macroglobulin inactive complex , 1989, The Journal of cell biology.

[4]  H. Moses,et al.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Massagué,et al.  The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. , 1986, The Journal of biological chemistry.

[6]  R. Ross,et al.  PLATELET-DERIVED GROWTH FACTOR , 1989, The Lancet.

[7]  Jan-Kan Chen,et al.  Differential inhibitory effects of TGF‐β on EGF‐, PDGF‐, and HBGF‐1‐stimulated MG63 human osteosarcoma cell growth: Possible involvement of growth factor interactions at the receptor and postreceptor levels , 1989, Journal of cellular physiology.

[8]  R. Ross,et al.  Role of serum components in density-dependent inhibition of growth of cells in culture. Platelet-derived growth factor is the major serum determinant of saturation density , 1980, The Journal of cell biology.

[9]  L M Wakefield,et al.  Distribution and modulation of the cellular receptor for transforming growth factor-beta , 1987, The Journal of cell biology.

[10]  T. Ogihara,et al.  Radioimmunoassay of human platelet-derived growth factor using monoclonal antibody toward a synthetic 73-97 fragment of its B-chain. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[11]  C. Heldin,et al.  Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. , 1989, The Journal of biological chemistry.

[12]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[13]  J. Weatherbee,et al.  Transforming growth factor‐β1 binds to immobilized fibronectin , 1989 .

[14]  B. H. Davis.  Transforming growth factor β responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture , 1988, Journal of cellular physiology.

[15]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[16]  H. Moses,et al.  Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Morris,et al.  Regulation of protein synthesis in mitogen-activated bovine lymphocytes. Analysis of actin-specific and total mRNA accumulation and utilization. , 1983, The Journal of biological chemistry.

[18]  H. Moses,et al.  Transforming growth factors and the regulation of cell proliferation. , 1990, European journal of biochemistry.

[19]  R. Ross,et al.  Synthesis, phosphorylation, and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody. , 1987, The Journal of biological chemistry.

[20]  R. Majack.  Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures , 1987, The Journal of cell biology.

[21]  R. Ross,et al.  The platelet-derived growth factor , 1978, Cell.

[22]  R. Ross,et al.  Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. , 1990, Biochemistry.

[23]  D. Hill,et al.  Bi‐functional action of transforming growth factor‐β on DNA synthesis in early passage human fetal fibroblasts , 1986, Journal of cellular physiology.

[24]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[25]  R. Stein,et al.  Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Canalis,et al.  Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.

[27]  W. Mckeehan,et al.  Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Massagué.  The TGF-β family of growth and differentiation factors , 1987, Cell.

[29]  S. Dower,et al.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. , 1989, Science.

[30]  O. Katoh,et al.  Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. , 1989, British journal of haematology.

[31]  M. Sporn,et al.  Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.

[32]  Gary R. Grotendorst,et al.  TGF‐β stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF‐related peptides , 1989 .

[33]  P. Libby,et al.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. , 1988, The Journal of clinical investigation.

[34]  P. Phillips,et al.  Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.

[35]  P. Månsson,et al.  High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. , 1988, The Journal of biological chemistry.

[36]  R. Ross,et al.  Two classes of PDGF receptor recognize different isoforms of PDGF. , 1988, Science.

[37]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Gown,et al.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis. , 1990, Science.

[39]  R. Ross,et al.  Purification of human platelet-derived growth factor. , 1985, Methods in Enzymology.

[40]  R. Eddy,et al.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines , 1986, Nature.

[41]  M. J. Newman,et al.  Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen. , 1989, The Journal of biological chemistry.

[42]  S. Aaronson,et al.  Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. , 1989, Science.

[43]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[44]  M. Sporn,et al.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.

[45]  C. Heldin,et al.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. , 1988, The EMBO journal.

[46]  G. Liau,et al.  Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. , 1989, The Journal of biological chemistry.

[47]  D. Bowen-Pope,et al.  Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-beta. , 1989, The Journal of biological chemistry.

[48]  M. Sporn,et al.  Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin. , 1990, The Journal of biological chemistry.

[49]  C. Heldin,et al.  Density-dependent inhibition of cell growth by transforming growth factor-beta 1 in normal human fibroblasts. , 1988, Growth factors.

[50]  S. Orkin,et al.  Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis , 1985, Nature.

[51]  R. Ross,et al.  The B chain of PDGF alone is sufficient for mitogenesis. , 1985, The EMBO journal.

[52]  Gary R. Grotendorst,et al.  TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression , 1987, Cell.

[53]  Denis Vivien,et al.  Differential effects of transforming growth factor‐β and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes , 1990, Journal of cellular physiology.

[54]  R. Ross,et al.  Methods for studying the platelet-derived growth factor receptor. , 1985, Methods in enzymology.

[55]  M. Sporn,et al.  Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.